Increased interaction between β-TrCP and Cyclin D1 was shown to promote Cyclin D1 protelysis in LNCap cells with exposure of peroxisome proliferator-activated receptor-γ (PPARγ) agonist STG28 and thereby contributed to its anti-tumor activity [22]. Here, BTRC is linked to neoplasm.